Literature DB >> 32358511

Prevalence of erectile dysfunction in patients with chronic kidney disease: a systematic review and meta-analysis.

Damiano Pizzol1, Tao Xiao2, Lin Yang3,4, Jacopo Demurtas5, Daragh McDermott6, Andrea Garolla7, Antonella Nardelotto8, Igor Grabovac9, Pinar Soysal10, Rumeyza Turan Kazancioglu11, Nicola Veronese12, Lee Smith13.   

Abstract

Growing evidence reports that chronic kidney diseases (CKD) might play a role in erectile dysfunction (ED), but limited knowledge is available. Therefore, we performed a systematic review up to 21/08/2019 to investigate the associations between CKD and ED. The main analysis reported the prevalence of ED as absolute estimates (in %) with their 95% confidence intervals (CIs) and across CKD stages (when specified), hemodialysis and transplant, calculating the p for interaction across strata. Among 291 studies, we included 34 articles with 5986 men. We found an overall prevalence of 76% (95%CI: 72-79) with a high degree of heterogeneity (I2 = 84.2%; p < 0.0001). Analyzing the data by CKD stage, we found a significant higher prevalence of ED in CKD (78%; 95%CI: 75-81%; I2 = not possible) compared with hemodialysis stage (prevalence = 77%; 95%CI: 73-80%; I2 = 84.5) or to patients undergoing transplant (prevalence = 64%; 95%CI: 54-74%; I2 = 54%) (p across strata = 0.036). Considering the high prevalence of ED in men with CKD, health care practitioners should focus on issues of sexual health in men with CKD. Given the advancements in dialysis and therapy and the associated advancements in survival and life expectancy, maintaining the patients' sexual function is important for their well-being and quality of life.
© 2020. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2020        PMID: 32358511     DOI: 10.1038/s41443-020-0295-8

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  21 in total

1.  Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research.

Authors:  E F Lizza; R C Rosen
Journal:  Int J Impot Res       Date:  1999-06       Impact factor: 2.896

2.  Sexual dysfunction after renal replacement therapy.

Authors:  W L Diemont; P A Vruggink; E J Meuleman; W H Doesburg; W A Lemmens; J H Berden
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 3.  Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies.

Authors:  Sankar D Navaneethan; Mariacristina Vecchio; David W Johnson; Valeria Saglimbene; Giusi Graziano; Fabio Pellegrini; Giuseppe Lucisano; Jonathan C Craig; Marinella Ruospo; Giorgio Gentile; Valeria Maria Manfreda; Marialuisa Querques; Paul Stroumza; Marietta Torok; Eduardo Celia; Ruben Gelfman; Juan Nin Ferrari; Anna Bednarek-Skublewska; Jan Dulawa; Carmen Bonifati; Jörgen Hegbrant; Charlotta Wollheim; Emmanuele A Jannini; Giovanni F M Strippoli
Journal:  Am J Kidney Dis       Date:  2010-10       Impact factor: 8.860

Review 4.  Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease.

Authors:  Biff F Palmer
Journal:  Adv Ren Replace Ther       Date:  2003-01

Review 5.  High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies.

Authors:  Y Kouidrat; D Pizzol; T Cosco; T Thompson; M Carnaghi; A Bertoldo; M Solmi; B Stubbs; N Veronese
Journal:  Diabet Med       Date:  2017-07-18       Impact factor: 4.359

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 8.  Sexual and reproductive function in end-stage renal disease and effect of kidney transplantation.

Authors:  Mahboob Lessan-Pezeshki; Shirin Ghazizadeh
Journal:  Asian J Androl       Date:  2007-12-20       Impact factor: 3.285

Review 9.  Chronic kidney disease: global dimension and perspectives.

Authors:  Vivekanand Jha; Guillermo Garcia-Garcia; Kunitoshi Iseki; Zuo Li; Saraladevi Naicker; Brett Plattner; Rajiv Saran; Angela Yee-Moon Wang; Chih-Wei Yang
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

Review 10.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.